The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease

The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease The FDA recently approved Flourodopa F18 (F-Dopa), a radioactive tracer for positron emission tomography (PET) that can help visualize the nerve endings of dopaminergic neurons. It can be used to help in the diagnosis of Parkinson’s disease (PD) and other parkinsonian […]

Read More

Deep brain stimulation and swimming

Deep brain stimulation and swimming Deep brain stimulation (DBS) is a surgical treatment for Parkinson’s disease (PD) symptoms in which small wires are inserted deep into the brain to deliver electrical current that allows for maintenance of more normal movement. DBS is particularly helpful for those with medication-resistant tremors as well as for those who […]

Read More

Promising results from the University of Pittsburgh APDA Center for Advanced Research

Promising results from the University of Pittsburgh APDA Center for Advanced Research Building off of pivotal APDA-funded work highlighted here, Dr. J. Timothy Greenamyre and his team, published a new study  investigating the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease (PD). LRRK2 is known to be mutated in a small […]

Read More

Taking Parkinson’s education to the farmers market: educating under-served communities

Taking Parkinson’s education to the farmers market: educating under-served communities Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian Medical Center in New York City, attended APDA’s Diversity in Parkinson’s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi  had just spent the day learning about health care disparities in PD care, low […]

Read More

New medication, Istradefylline, gets approved for Parkinson’s disease

New medication, Istradefylline, gets approved for Parkinson’s disease On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […]

Read More